ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL

被引:0
|
作者
Ji-Yu Li
Yu-Yang Li
Wei Jin
Qing Yang
Zhi-Ming Shao
Xing-Song Tian
机构
[1] Provincial Hospital Affiliated to Shandong University,Department of Breast and Thyroid Surgery
[2] The Second Hospital of Shandong University,Department of Breast Surgery
[3] Breast Cancer Institute,Department of Breast Surgery
[4] Shanghai Cancer Center,undefined
[5] Shanghai Medical College,undefined
[6] Fudan University,undefined
来源
Journal of Experimental & Clinical Cancer Research | / 31卷
关键词
ABT-737; Breast cancer; Acquired radioresistance; Radiation; Bcl-2; Bcl-xL;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL
    Li, Ji-Yu
    Li, Yu-Yang
    Jin, Wei
    Yang, Qing
    Shao, Zhi-Ming
    Tian, Xing-Song
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [2] A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma
    Chauhan, D.
    Velankar, M.
    Brahmandam, M.
    Hideshima, T.
    Podar, K.
    Richardson, P.
    Schlossman, R.
    Ghobrial, I.
    Raje, N.
    Munshi, N.
    Anderson, K. C.
    ONCOGENE, 2007, 26 (16) : 2374 - 2380
  • [3] A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma
    D Chauhan
    M Velankar
    M Brahmandam
    T Hideshima
    K Podar
    P Richardson
    R Schlossman
    I Ghobrial
    N Raje
    N Munshi
    K C Anderson
    Oncogene, 2007, 26 : 2374 - 2380
  • [4] Bcl-xL stimulates Bax relocation to mitochondria and primes cells to ABT-737
    Renault, Thibaud T.
    Teijido, Oscar
    Missire, Florent
    Ganesan, Yogesh Tengarai
    Velours, Gisele
    Arokium, Hubert
    Beaumatin, Florian
    Llanos, Raul
    Athane, Axel
    Camougrand, Nadine
    Priault, Muriel
    Antonsson, Bruno
    Dejean, Laurent M.
    Manon, Stephen
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2015, 64 : 136 - 146
  • [5] Mitochondrial fragmentation and neuronal cell death in response to the Bcl-2/Bcl-xL/Bcl-w antagonist ABT-737
    Young, Kenneth W.
    Pinon, Lucia G. P.
    Dhiraj, Dalbir
    Twiddy, Davina
    MacFarlane, Marion
    Hickman, John
    Nicotera, Pierluigi
    NEUROPHARMACOLOGY, 2010, 58 (08) : 1258 - 1267
  • [6] ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells
    Parrondo, Ricardo
    de las Pozas, Alicia
    Reiner, Teresita
    Perez-Stable, Carlos
    PEERJ, 2013, 1
  • [7] Bcl-2/Bcl-xL inhibitor ABT-737 sensitizes pancreatic ductal adenocarcinoma to paclitaxel-induced cell death
    Kasai, Shuya
    Sasaki, Takuya
    Watanabe, Ayano
    Nishiya, Masao
    Yasuhira, Shinji
    Shibazaki, Masahiko
    Maesawa, Chihaya
    ONCOLOGY LETTERS, 2017, 14 (01) : 903 - 908
  • [8] Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine A
    Pietro E. Cippà
    Jivko Kamarashev
    Jin Chen
    Anna K. Kraus
    Stephan Segerer
    Laurence Feldmeyer
    Thomas Fehr
    Apoptosis, 2013, 18 : 315 - 323
  • [9] Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine A
    Cippa, Pietro E.
    Kamarashev, Jivko
    Chen, Jin
    Kraus, Anna K.
    Segerer, Stephan
    Feldmeyer, Laurence
    Fehr, Thomas
    APOPTOSIS, 2013, 18 (03) : 315 - 323
  • [10] The Bcl-2 Homology Domain 3 (BH3) Mimetic ABT-737 Reveals the Dynamic Regulation of Bad, a Proapoptotic Protein of the Bcl-2 Family, by Bcl-xL
    Ezzoukhry, Zakaria
    Louandre, Christophe
    Francois, Catherine
    Saidak, Zuzana
    Godin, Corinne
    Maziere, Jean-Claude
    Galmiche, Antoine
    MOLECULAR PHARMACOLOGY, 2011, 79 (06) : 997 - 1004